Botulinum Toxin A Merz - Biotech, Pharma and Life Science Channel

01:05 EDT 31st July 2015 | BioPortfolio

PubMed Articles [658 Associated PubMed Articles listed on BioPortfolio]

Three-Dimensional Innervation Zone Imaging from Multi-Channel Surface EMG Recordings.

There is an unmet need to accurately identify the locations of innervation zones (IZs) of spastic muscles, so as to guide botulinum toxin (BTX) injections for the best clinical outcome. A novel 3D IZ ...

Achalasia: current treatment options.

Achalasia is a rare esophageal motility disorder, characterized by impaired swallow-induced, lower esophageal sphincter (LES) relaxation and defective esophageal peristalsis. Unfortunately, there are ...

Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): A 12-year experience in more than 900 patients.

Effect of Botulinum Toxin Type A on Differentiation of Fibroblasts Derived from Scar Tissue.

Although botulinum toxin type A has been shown to inhibit the formation of hypertrophic scars, little is known about the underlying mechanisms of action. Studies have reported that botulinum toxin typ...

Visualization of Lipid Membrane Reorganization Induced by a Pore-Forming Toxin Using High-Speed Atomic Force Microscopy.

We examined the effect of a sphingomyelin (SM)-binding pore-forming toxin (PFT), lysenin, on the dynamics of a phase-separated membrane of SM, where SM formed liquid-ordered (Lo) domains with choleste...

Assessment of Shiga Toxin-Producing Escherichia coli O157 Illnesses Prevented by Recalls of Beef Products.

Beef product recall data from 2005 through 2012 associated with Shiga toxin-producing Escherichia coli (STEC) O157 contamination were used to develop quantitative models to estimate the number of illn...

Experimental studies of microbial populations and incidence of zoonotic pathogens in the faeces of red deer (Cervus elaphus).

Wild animals can serve as hosts, amplifiers, or reservoirs for various zoonotic diseases. Most species of deer in highly fragmented agricultural landscapes, search out maximum cover from intrusive hum...

A afferent fibers are involved in the pathology of central changes in the spinal dorsal horn associated with myofascial trigger spots in rats.

A afferent fibers have been reported to participate in the development of the central sensitization induced by inflammation and injuries. Current evidence suggests that myofascial trigger points (MTrP...

Biochemical and growth performance of the aquatic macrophyte Azolla filiculoides to sub-chronic exposure to cylindrospermopsin.

Physiological and biochemical effects of cylindrospermopsin (CYN), a cyanobacterial toxin that inhibits protein synthesis and released during a harmful cyanobacterial bloom, has been overlooked in pla...

Transfer of microcystin from freshwater lakes to Puget Sound, WA and toxin accumulation in marine mussels (Mytilus trossulus).

Many eutrophic inland freshwater lakes in the Puget Sound Washington region produce toxic cyanobacteria blooms annually. While such blooms in lakes tend to be viewed as a localized phenomenon, there i...

News Articles [201 Associated News Articles listed on BioPortfolio]

Bloomage and Medytox set up JV to develop botulinum toxin market in China

Hong Kong-based Bloomage BioTechnology Corp has entered a strategic cooperation with the South Korean…

China's Bloomage Forms Botox JV with Medytox of South Korea

Bloomage BioTechnology formed a JV with South Korea's Medytox to market Medytox's version of the wrinkle treatment Botox (Botulinum Toxin) in China. The JV, which will be owned 50-50 by the two partne...

Frozen Food Foundation Names Dr. Erdogan Ceylan of Silliker 2015 Freezing Research Award Recipient

The Frozen Food Foundation, in conjunction with the International Association for Food Protection (IAFP), this week presented Dr. Erdogan Ceylan of the

Medytox In China JV Deal, Aims To Set Up More Asian Units

After the establishment of its first overseas subsidiary in Taiwan early this year, Medytox has set up a joint venture with China's Bloomage BioTechnology to sell its botulinum toxin products and hyal...

Bloomage (00963.HK) and Medytox Inc. set up a Joint Venture To Jointly Develop Botulinum Toxin Market in China

HONG KONG, July 27, 2015 /PRNewswire/ -- Bloomage BioTechnology Corporation Limited ("Bloomage" or "The Company", Stock Code: 00963.HK) announces a strategic cooperation with the South Korean BioTech ...

Neogen launches NeoSeek™ Salmonella serotyping service

LANSING, Mich., July 27, 2015 /PRNewswire/ -- Neogen Corporation (Nasdaq: NEOG) today announced the development of a detection and identification technology that provides DNA-specific test results for...

Toxin from salmonid fish has potential to treat cancer

(BIOSS - Centre for Biological Signalling Studies) Pathogenic bacteria develop killer machines that work very specifically and highly efficiently. Scientists from the University of Freiburg have solve...

CMV CC chemokine receptor (US28)

In vitro and mouse studies identified a bacterial toxin-based inhibitor of US28 that could help treat human cytomegalovirus (HCMV) infection.

U.S. E. coli O157 outbreaks mainly due to food

(HealthDay)—Outbreaks of Shiga toxin-producing bacterium Escherichia coli O157 infection are mainly caused by food, especially beef and leafy vegetables, according to a study published in the August...

Ipsen announces FDA approval of Dysport® (abobotulinumtoxinA) for injection in the treatment of upper limb spasticity in adults in the United States

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental Biologics License...

Events [0 Results]

None

Companies [8 Associated Companies listed on BioPortfolio]

Pharmaleads

Pharmaleads is a research company focussed on the custom design of substrates and inhibitors of zinc metallopeptidases and proteases. Pharmaleads has already developed molecules for ECE, NEP, ACE, APN...

OCuSOFT, Inc.

OCuSOFT, Inc. is a privately-held Richmond, TX USA-based ophthalmic research, development and supply company with an established reputation for innovation, particularly in the are...

Merz North America, Inc.

Merz North America is a specialty healthcare company that develops and commercializes innovative treatment solutions in medical and aesthetic dermatology, and neurology in the U.S...

Merz North America

Merz North America is a specialty healthcare company that develops and commercializes innovative treatment solutions in aesthetics, dermatology and neurology in the U.S. and Canad...

Merz, Inc.

Merz, Inc. is a focused specialty healthcare company that is responsible for developing and commercializing innovative products and solutions in neurology, medical aesthetics, and...

Molecular Templates

Molecular Templates is a biopharmaceutical company focused on the discovery and development of targeted biologic therapeutics using its novel Engineered Toxin Bodies (ETB) platfor...

Merz Aesthetics

Merz Aesthetics, the new business unit of Merz Pharma Group, is a leader in the global aesthetic medicine market. With a 100-year history of compassion and innovation in healthcare, Merz Aesthetics i...

DentaSpa

DentaSpa™ is one of the nation’s leading Botulinum Toxin, dermal fillers and injectables business education companies tailored exclusively for dental practitioners. Dent...

Clinical Trials [235 Associated Clinical Trials listed on BioPortfolio]

Pertussis Immunization During Pregnancy: Effect in Term and Preterm Infants

Young infants are most vulnerable to severe disease and even death when infected with Bordetella Pertussis. The current vaccines and vaccination programs do not guarantee protection of neo...

The Effectiveness of Early Botulinum Toxin A Injection for Lower Limbs Spasticity in Subacute Stroke Adults

Botulinum toxin A (BoNT-A) injections are widely used to treat spasticity after stroke. Although this treatment is effective on muscle tone improvement, its effect on gait and ability of d...

Temporary Autonomic Blockade to Prevent Atrial Fibrillation After Cardiac Surgery

In this study, the investigators aim to determine whether injecting botulinum toxin into epicardial fat pads is efficacious and safe for decreasing postoperative atrial fibrillation (POAF)...

Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines

The purpose of the protocol is to demonstrate the safety and the efficacy of a single injection of a new formulation of Clostridium Botulinum toxin type A haemagglutinin complex (BTX A HAC...

Two-week Course Versus Conventionally Fractionated Chemoradiotherapy in Rectal Cancer

The investigators compare two-week course of chemoradiation (33 Gy in 10 fractions with oral capecitabine) and conventional chemoradiation (50.4 Gy in 28 fractions with 5-FU and leucovorin...

Intra Individual Evaluation of Uremic Toxin Levels in Hemodialysed Patients

Chronic kidney disease (CKD) is characterized by a irreversible decrease of kidney functions. It is characterized by accumulation of solutes called uremic toxins. Uremic toxins levels are ...

The Use of Botox in Advanced Parkinson's Patients Experiencing Pain

Most Parkinsonism related pain can be assigned to one or more of five categories: musculoskeletal pain, neuritic or radicular pain, dystonia associated pain, primary or central pain, and a...

Botulinim Toxin Type A Injections by Different Guidance in Stroke Patients With Spasticity on Lower Extremities

Stroke may result in lower extremity spasticity, which interfere with motor voluntary function and activities of daily living. Botulinum toxin type A (BTX-A) has been shown to improve lowe...

Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the Eyelid

This phase 3 study will serve to collect efficacy and safety data of two different doses of NT 201 in subjects suffering from Bilateral Blephorasm (BEB) who are BTX treatment-naïve. In t...

BOTOX® Treatment in Pediatric Lower Limb Spasticity

This study will evaluate the safety and efficacy of BOTOX® (botulinum toxin Type A) in pediatric patients with lower limb spasticity.

Videos

None available.

Medical and Biotech [MESH] Definitions

Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type C which is neurotoxic to ANIMALS, especially CATTLE, but not humans. It causes dissociation of ACTIN FILAMENTS.

Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type D which is neurotoxic to ANIMALS, especially CATTLE, but not humans.

Subtype of CLOSTRIDIUM BOTULINUM that produces BOTULINUM TOXIN TYPE A which is neurotoxic to humans and animals.

Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type B which is neurotoxic to humans and animals.

Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type E which is neurotoxic to humans and animals.


Advertisement
 
Advertisement
 
review and buy Botulinum Toxin A Merz market research data and corporate reports here

Channels Quicklinks